Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial

BACKGROUND/AIMS: The current study evaluates the efficacy and safety of the stand-alone implantation of the MINIject (iSTAR Medical, Wavre, Belgium) supraciliary, microinvasive glaucoma drainage device in patients with medically uncontrolled open-angle glaucoma. METHODS: This prospective, multicentr...

Descripción completa

Detalles Bibliográficos
Autores principales: Denis, Philippe, Hirneiß, Christoph, Durr, Georges M, Reddy, Kasu Prasad, Kamarthy, Anita, Calvo, Ernesto, Hussain, Zubair, Ahmed, Iqbal K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685654/
https://www.ncbi.nlm.nih.gov/pubmed/33011690
http://dx.doi.org/10.1136/bjophthalmol-2020-316888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685654/
https://www.ncbi.nlm.nih.gov/pubmed/33011690
http://dx.doi.org/10.1136/bjophthalmol-2020-316888

Ejemplares similares